01 1SMS Pharmaceuticals
01 1ESCITALOPRAM OXALATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-05-13
Pay. Date : 2025-04-11
DMF Number : 40721
Submission : 2024-11-05
Status : Active
Type : II
20
Sms Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ESCITALOPRAM OXALATE USP, with a corresponding US DMF Number 40721.
Remarkably, this DMF maintains an Active status since its submission on November 05, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 13, 2025, and payment made on April 11, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
